Atlas Trials

A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations

Clinical trial NCT03000348 · COMPLETED

Trial details

NCT number
NCT03000348
Sponsor
NovaBiotics Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2016-12-01
Primary completion
2018-04-01
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.